Header cover image

U.S. Strong Balance Sheet Stocks

U.S. Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

3,916 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
SPRTSupport.comUS$11.80-49.1%478.4%US$286.0mn/aPS7.3xn/an/aSoftware
ANIXAnixa BiosciencesUS$4.34-1.1%92.0%US$130.0mUS$11.00PS253.7xE-8.3%n/aPharmaceuticals & Biotech
CYTRCytRxUS$0.550%-6.1%US$21.3mn/aPB3.3xn/an/aPharmaceuticals & Biotech
REFRResearch FrontiersUS$2.25-2.6%-24.0%US$71.2mn/aPS114.3xn/an/aTech
DDD3D SystemsUS$26.782.6%249.6%US$3.4bUS$27.71PS5.4xE-28.3%n/aTech
ISIGInsignia SystemsUS$7.596.9%26.1%US$13.4mn/aPB2.6xn/an/aMedia
BYFCBroadway FinancialUS$2.95-7.5%52.1%US$211.7mn/aPB1.5xn/a0%Banks
ENGENGlobalUS$2.25-3.8%147.3%US$79.1mn/aPS1.6xn/an/aEnergy
NTZNatuzziUS$18.22-2.8%165.2%US$199.9mn/aPB2.1xn/an/aConsumer Durables
UAMYUnited States AntimonyUS$0.84-2.1%121.7%US$88.8mn/aPS16.3xn/an/aMaterials
MACKMerrimack PharmaceuticalsUS$4.56-10.2%18.4%US$61.2mn/aPB4.1xn/an/aPharmaceuticals & Biotech
BCLIBrainstorm Cell TherapeuticsUS$3.080%-71.3%US$126.4mUS$11.50PB4.2xE50.2%n/aPharmaceuticals & Biotech
CLDXCelldex TherapeuticsUS$47.392.6%190.4%US$2.2bUS$64.83PS255.6xE-18.5%n/aPharmaceuticals & Biotech
SRRASierra OncologyUS$20.10-5.6%57.6%US$252.5mUS$33.20PS841.7xE42.2%n/aPharmaceuticals & Biotech
IGCIndia Globalization CapitalUS$1.41-3.4%12.8%US$72.0mn/aPS184.1xn/an/aCapital Goods
AMPEAmpio PharmaceuticalsUS$1.62-4.7%99.2%US$324.7mUS$4.00PB15.9xE1.9%n/aPharmaceuticals & Biotech
MDGLMadrigal PharmaceuticalsUS$78.31-9.1%-40.2%US$1.3bUS$170.08PB4.8xE47.4%n/aPharmaceuticals & Biotech
ANYSphere 3DUS$6.50-18.8%291.6%US$382.3mn/aPS80xn/an/aSoftware
IPWRIdeal PowerUS$14.55-2.5%148.5%US$85.4mUS$28.00PS114.2xE8.1%n/aCapital Goods
USAUU.S. GoldUS$10.070.2%16.0%US$71.4mUS$17.75PB2.6xn/an/aMaterials
NAOVNanoVibronixUS$1.51-7.4%118.7%US$37.6mn/aPS57xn/an/aHealthcare
GIGAGiga-tronicsUS$2.971.6%-29.4%US$8.1mn/aPB11.7xn/an/aCapital Goods
ABCPAmBaseUS$0.3513.2%5.0%US$14.1mn/aPB3xn/a0%Real Estate
GTBPGT BiopharmaUS$6.466.8%63.2%US$196.9mUS$25.33PB5.4xE-20.2%n/aPharmaceuticals & Biotech
Page 1 of 164